Valsts: Austrālija
Valoda: angļu
Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)
Gymnema sylvestre, Quantity: 125 mg (Equivalent: Gymnema sylvestre, Qty 2 g); Cinnamomum cassia, Quantity: 125 mg (Equivalent: Cinnamomum cassia, Qty 1.5 g; Equivalent: coumarin, Qty 0.0001 mg); Mangifera indica, Quantity: 40 mg (Equivalent: Mangifera indica, Qty 1000 mg); Morus alba, Quantity: 50 mg (Equivalent: Morus alba, Qty 300 mg); Cordyceps sinensis, Quantity: 10 mg; chromium picolinate, Quantity: 133.5 microgram (Equivalent: chromium, Qty 16.6 microgram); Lycium barbarum, Quantity: 20 mg; heavy magnesium oxide, Quantity: 83 mg (Equivalent: magnesium, Qty 50 mg); Momordica charantia, Quantity: 50 mg (Equivalent: Momordica charantia, Qty 750 mg); Ganoderma lucidum, Quantity: 10 mg (Equivalent: Ganoderma lucidum, Qty 100 mg); alpha lipoic acid, Quantity: 20 mg
Concord International Trading Pty Ltd
alpha lipoic acid,Chromium picolinate,Cinnamomum cassia,Cordyceps sinensis,Ganoderma lucidum,Gymnema sylvestre,heavy magnesium o
Tablet, uncoated
Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate
Oral
Maintain/support general health and wellbeing ; Helps maintain/support healthy blood sugar/glucose ; Aid/assist/helps glucose/sugar/carbohydrate metabolism
Visual Identification: ;
Licence status A
2015-10-23